{"id":"https://openalex.org/W4386190890","doi":"https://doi.org/10.1007/s40268-023-00437-3","title":"Demonstration of Physicochemical and Functional Similarity of Biosimilar Adalimumab-aqvh to Adalimumab","display_name":"Demonstration of Physicochemical and Functional Similarity of Biosimilar Adalimumab-aqvh to Adalimumab","publication_year":2023,"publication_date":"2023-08-26","ids":{"openalex":"https://openalex.org/W4386190890","doi":"https://doi.org/10.1007/s40268-023-00437-3","pmid":"https://pubmed.ncbi.nlm.nih.gov/37632627","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10676336"},"language":"en","primary_location":{"id":"doi:10.1007/s40268-023-00437-3","doi":"https://doi.org/10.1007/s40268-023-00437-3","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40268-023-00437-3","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40268-023-00437-3.pdf","source":{"id":"https://openalex.org/S35266406","display_name":"Drugs in R&D","issn_l":"1174-5886","issn":["1174-5886","1179-6901"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","norway-1","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs in R&D","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://link.springer.com/content/pdf/10.1007/s40268-023-00437-3.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064558634","display_name":"Y. Jiang","orcid":"https://orcid.org/0009-0009-7420-4966","observed_orcids":["https://orcid.org/0009-0009-7420-4966"]},"institutions":[{"id":"https://openalex.org/I4210100603","display_name":"Coherus BioSciences (United States)","ror":"https://ror.org/00mjj2d85","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100603"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yijia Jiang","raw_affiliation_strings":["Coherus BioSciences Inc., 1000 Avenida Acaso, Camarillo, CA, 93012, USA"],"raw_orcid":"https://orcid.org/0009-0009-7420-4966","affiliations":[{"raw_affiliation_string":"Coherus BioSciences Inc., 1000 Avenida Acaso, Camarillo, CA, 93012, USA","institution_ids":["https://openalex.org/I4210100603"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Taruna Arora","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]},{"id":"https://openalex.org/I4210100603","display_name":"Coherus BioSciences (United States)","ror":"https://ror.org/00mjj2d85","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100603"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Taruna Arora","raw_affiliation_strings":["Bristol Myers Squibb Inc., Redwood City, CA, USA","Coherus BioSciences Inc., 1000 Avenida Acaso, Camarillo, CA, 93012, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb Inc., Redwood City, CA, USA","institution_ids":["https://openalex.org/I4210091812"]},{"raw_affiliation_string":"Coherus BioSciences Inc., 1000 Avenida Acaso, Camarillo, CA, 93012, USA","institution_ids":["https://openalex.org/I4210100603"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030976019","display_name":"Scott L. Klakamp","orcid":"https://orcid.org/0000-0002-1231-9655","observed_orcids":["https://orcid.org/0000-0002-1231-9655"]},"institutions":[{"id":"https://openalex.org/I4210100603","display_name":"Coherus BioSciences (United States)","ror":"https://ror.org/00mjj2d85","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100603"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott Klakamp","raw_affiliation_strings":["Coherus BioSciences Inc., 1000 Avenida Acaso, Camarillo, CA, 93012, USA"],"raw_orcid":"https://orcid.org/0000-0002-1231-9655","affiliations":[{"raw_affiliation_string":"Coherus BioSciences Inc., 1000 Avenida Acaso, Camarillo, CA, 93012, USA","institution_ids":["https://openalex.org/I4210100603"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028803982","display_name":"J.Lawrence Davis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100603","display_name":"Coherus BioSciences (United States)","ror":"https://ror.org/00mjj2d85","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100603"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Janice Davis","raw_affiliation_strings":["Coherus BioSciences Inc., 1000 Avenida Acaso, Camarillo, CA, 93012, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Coherus BioSciences Inc., 1000 Avenida Acaso, Camarillo, CA, 93012, USA","institution_ids":["https://openalex.org/I4210100603"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058097984","display_name":"Yasmin A. Chandrasekher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100603","display_name":"Coherus BioSciences (United States)","ror":"https://ror.org/00mjj2d85","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100603"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yasmin A. Chandrasekher","raw_affiliation_strings":["Coherus BioSciences Inc., Redwood City, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Coherus BioSciences Inc., Redwood City, CA, USA","institution_ids":["https://openalex.org/I4210100603"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102721562","display_name":"Glen W. Young","orcid":"https://orcid.org/0009-0005-4105-8721","observed_orcids":["https://orcid.org/0009-0005-4105-8721"]},"institutions":[{"id":"https://openalex.org/I4210100603","display_name":"Coherus BioSciences (United States)","ror":"https://ror.org/00mjj2d85","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100603"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Glen Young","raw_affiliation_strings":["Coherus BioSciences Inc., 1000 Avenida Acaso, Camarillo, CA, 93012, USA"],"raw_orcid":"https://orcid.org/0009-0005-4105-8721","affiliations":[{"raw_affiliation_string":"Coherus BioSciences Inc., 1000 Avenida Acaso, Camarillo, CA, 93012, USA","institution_ids":["https://openalex.org/I4210100603"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103157295","display_name":"Yue Du","orcid":"https://orcid.org/0009-0007-7422-3222","observed_orcids":["https://orcid.org/0009-0007-7422-3222"]},"institutions":[{"id":"https://openalex.org/I4210100603","display_name":"Coherus BioSciences (United States)","ror":"https://ror.org/00mjj2d85","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100603"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yue Du","raw_affiliation_strings":["Coherus BioSciences Inc., 1000 Avenida Acaso, Camarillo, CA, 93012, USA"],"raw_orcid":"https://orcid.org/0009-0007-7422-3222","affiliations":[{"raw_affiliation_string":"Coherus BioSciences Inc., 1000 Avenida Acaso, Camarillo, CA, 93012, USA","institution_ids":["https://openalex.org/I4210100603"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061035808","display_name":"Bin Yu","orcid":"https://orcid.org/0000-0002-3705-0453","observed_orcids":["https://orcid.org/0000-0002-3705-0453"]},"institutions":[{"id":"https://openalex.org/I4210100603","display_name":"Coherus BioSciences (United States)","ror":"https://ror.org/00mjj2d85","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100603"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bin Yu","raw_affiliation_strings":["Coherus BioSciences Inc., 1000 Avenida Acaso, Camarillo, CA, 93012, USA"],"raw_orcid":"https://orcid.org/0000-0002-3705-0453","affiliations":[{"raw_affiliation_string":"Coherus BioSciences Inc., 1000 Avenida Acaso, Camarillo, CA, 93012, USA","institution_ids":["https://openalex.org/I4210100603"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101855837","display_name":"Karen J. Miller","orcid":"https://orcid.org/0009-0001-8125-7187","observed_orcids":["https://orcid.org/0009-0001-8125-7187"]},"institutions":[{"id":"https://openalex.org/I4210100603","display_name":"Coherus BioSciences (United States)","ror":"https://ror.org/00mjj2d85","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100603"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Karen J. Miller","raw_affiliation_strings":["Coherus BioSciences Inc., 1000 Avenida Acaso, Camarillo, CA, 93012, USA. kmiller@coherus.com","Coherus BioSciences Inc., 1000 Avenida Acaso, Camarillo, CA, 93012, USA"],"raw_orcid":"https://orcid.org/0009-0001-8125-7187","affiliations":[{"raw_affiliation_string":"Coherus BioSciences Inc., 1000 Avenida Acaso, Camarillo, CA, 93012, USA. kmiller@coherus.com","institution_ids":["https://openalex.org/I4210100603"]},{"raw_affiliation_string":"Coherus BioSciences Inc., 1000 Avenida Acaso, Camarillo, CA, 93012, USA","institution_ids":["https://openalex.org/I4210100603"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5101855837"],"corresponding_institution_ids":["https://openalex.org/I4210100603"],"apc_list":{"value":3390,"currency":"USD","value_usd":3390},"apc_paid":{"value":3390,"currency":"USD","value_usd":3390},"fwci":0.7871,"has_fulltext":true,"cited_by_count":8,"citation_normalized_percentile":{"value":0.64407238,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"23","issue":"4","first_page":"377","last_page":"395"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adalimumab","display_name":"adalimumab","score":0.984000027179718},{"id":"https://openalex.org/keywords/biosimilarity","display_name":"biosimilarity","score":0.8479999899864197},{"id":"https://openalex.org/keywords/analytical-similarity","display_name":"analytical similarity","score":0.7300000190734863},{"id":"https://openalex.org/keywords/structural-characterization","display_name":"structural characterization","score":0.5090000033378601},{"id":"https://openalex.org/keywords/glycan-profiles","display_name":"glycan profiles","score":0.7630000114440918},{"id":"https://openalex.org/keywords/post-translational-modification","display_name":"post-translational modification","score":0.8420000076293945},{"id":"https://openalex.org/keywords/charge-variants","display_name":"charge variants","score":0.6320000290870667},{"id":"https://openalex.org/keywords/subvisible-particles","display_name":"subvisible particles","score":0.7960000038146973},{"id":"https://openalex.org/keywords/host-cell-proteins","display_name":"host cell proteins","score":0.9480000138282776},{"id":"https://openalex.org/keywords/forced-degradation","display_name":"forced degradation","score":0.8159999847412109},{"id":"https://openalex.org/keywords/stability","display_name":"stability","score":0.4009999930858612},{"id":"https://openalex.org/keywords/tnf-alpha-inhibitors","display_name":"TNF-alpha inhibitors","score":0.6209999918937683}],"concepts":[{"id":"https://openalex.org/C2780132546","wikidata":"https://www.wikidata.org/wiki/Q348260","display_name":"Adalimumab","level":3,"score":0.9901741743087769},{"id":"https://openalex.org/C59491497","wikidata":"https://www.wikidata.org/wiki/Q864715","display_name":"Biosimilar","level":2,"score":0.6230667233467102},{"id":"https://openalex.org/C139489369","wikidata":"https://www.wikidata.org/wiki/Q770846","display_name":"Structural similarity","level":2,"score":0.4765470623970032},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4186725616455078},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.29327893257141113},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.23122987151145935},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.11619329452514648},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.07389914989471436}],"mesh":[{"descriptor_ui":"D000068879","descriptor_name":"Adalimumab","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000068879","descriptor_name":"Adalimumab","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059451","descriptor_name":"Biosimilar Pharmaceuticals","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1007/s40268-023-00437-3","doi":"https://doi.org/10.1007/s40268-023-00437-3","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40268-023-00437-3","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40268-023-00437-3.pdf","source":{"id":"https://openalex.org/S35266406","display_name":"Drugs in R&D","issn_l":"1174-5886","issn":["1174-5886","1179-6901"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","norway-1","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs in R&D","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10676336","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10676336","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10676336/pdf/40268_2023_Article_437.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs R D","raw_type":"Text"},{"id":"pmid:37632627","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37632627","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs in R&D","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:01e48b8a69ff45c6a33685969a921169","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/01e48b8a69ff45c6a33685969a921169","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Drugs in R&D, Vol 23, Iss 4, Pp 377-395 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1007/s40268-023-00437-3","doi":"https://doi.org/10.1007/s40268-023-00437-3","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40268-023-00437-3","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40268-023-00437-3.pdf","source":{"id":"https://openalex.org/S35266406","display_name":"Drugs in R&D","issn_l":"1174-5886","issn":["1174-5886","1179-6901"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","norway-1","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs in R&D","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.8048999905586243,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320319840","display_name":"Coherus Biosciences","ror":"https://ror.org/00mjj2d85"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4386190890.pdf","grobid_xml":"https://content.openalex.org/works/W4386190890.grobid-xml"},"referenced_works_count":9,"referenced_works":["https://openalex.org/W1983379232","https://openalex.org/W2067367025","https://openalex.org/W2078111332","https://openalex.org/W2175291039","https://openalex.org/W2284253054","https://openalex.org/W2570660200","https://openalex.org/W2982395127","https://openalex.org/W3125470744","https://openalex.org/W3134454558"],"related_works":["https://openalex.org/W2551295995","https://openalex.org/W4200503089","https://openalex.org/W2475442004","https://openalex.org/W3034053981","https://openalex.org/W2897897389","https://openalex.org/W2463297336","https://openalex.org/W2979118709","https://openalex.org/W4320065008","https://openalex.org/W3173943503","https://openalex.org/W4303645566"],"abstract_inverted_index":{"BACKGROUND:":[0],")":[1],"(hereafter":[2],"referred":[3],"to":[4,28,129,175],"as":[5,17],"adalimumab-aqvh)":[6],"was":[7,26,96,116],"recently":[8],"approved":[9],"by":[10,98],"the":[11,30,36,135,156,162,176,196],"US":[12],"Food":[13],"and":[14,35,44,49,64,84,94,103,113,143,149,185,195],"Drug":[15],"Administration":[16],"a":[18,139],"biosimilar":[19],"for":[20],"adalimumab.":[21,39,199],"OBJECTIVE:":[22],"The":[23,41,56,89,109,122,182],"current":[24],"study":[25],"conducted":[27],"investigate":[29],"analytical":[31],"similarity":[32,91,136,165],"of":[33,47,111,114,125,131,164,179,191],"adalimumab-aqvh":[34,48,93,112,126,194],"reference":[37,197],"product,":[38,198],"METHODS:":[40],"structural,":[42,183],"functional,":[43,184],"stability":[45,110,147,186],"attributes":[46,124,158],"adalimumab":[50,95,115,132,144,177],"were":[51,87,127],"compared":[52,117],"using":[53],"state-of-the-art":[54],"assays.":[55],"primary":[57],"structure,":[58,60],"disulfide":[59],"glycan":[61],"profile,":[62],"secondary":[63],"tertiary":[65],"structures,":[66],"molar":[67],"mass,":[68],"size":[69],"variants,":[70,74,76],"free":[71],"thiol,":[72],"charge":[73],"hydrophobic":[75],"post-translational":[77],"modifications,":[78],"subvisible":[79],"particles,":[80],"host":[81],"cell":[82],"proteins,":[83],"protein":[85],"concentration":[86],"investigated.":[88],"functional":[90,150,172],"between":[92,193],"demonstrated":[97],"comparing":[99],"fragment":[100,104],"antigen-binding":[101],"(Fab)-associated":[102],"crystallizable":[105],"(Fc)-associated":[106],"biological":[107],"activities.":[108,151],"through":[118],"forced":[119],"degradation.":[120],"RESULTS:":[121],"structural":[123],"identical":[128],"those":[130],"or":[133],"met":[134],"criteria,":[137],"with":[138],"few":[140],"exceptions.":[141],"Adalimumab-aqvh":[142],"exhibited":[145],"comparable":[146],"profiles":[148],"Any":[152],"observed":[153],"differences":[154],"in":[155],"physiochemical":[157],"did":[159,168],"not":[160,169],"impact":[161],"conclusion":[163],"because":[166],"they":[167],"influence":[170],"any":[171],"activities":[173],"related":[174],"mechanism":[178],"action.":[180],"CONCLUSION:":[181],"data":[187],"provide":[188],"convincing":[189],"evidence":[190],"biosimilarity":[192]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":5},{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-08-27T00:00:00"}